CD8A and cancer: Both activated CD8+ T cells and NK cells show cytolytic activity against tumor cells by secreting several cytolytic molecules, such as granzyme A (GZMA), GZMB, and perforin (PRF1), showing good prognoses in various types of cancers [61,64].